Maravai LifeSciences
Maravai LifeSciences, a leading provider in the life sciences sector, is headquartered in the United States and operates across key regions globally. Founded in 2016, the company has rapidly established itself as a pivotal player in the biotechnology industry, focusing on critical areas such as nucleic acid production, protein detection, and cell culture solutions. Maravai's core offerings include high-quality reagents and services that support the development of therapeutics and diagnostics. Their unique approach to custom synthesis and scalable production sets them apart in a competitive market. With a commitment to innovation, Maravai has achieved significant milestones, including strategic acquisitions that enhance their capabilities and market reach. Recognised for their excellence, Maravai LifeSciences continues to drive advancements in life sciences, contributing to the global health landscape.
DitchCarbon Score
How does Maravai LifeSciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Maravai LifeSciences's score of 28 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Maravai LifeSciences's reported carbon emissions
In 2023, Maravai LifeSciences reported significant carbon emissions, totalling approximately 15,490,000 kg CO2e across all scopes. This includes 1,549,000 kg CO2e from Scope 1, 1,993,000 kg CO2e from Scope 2, and a substantial 11,948,000 kg CO2e from Scope 3 emissions, which encompass categories such as capital goods and purchased goods and services. In 2022, the company’s emissions were about 1,680,000 kg CO2e for Scope 1 and 1,309,000 kg CO2e for Scope 2, reflecting a slight increase in emissions compared to the previous year. The Scope 1 emissions in 2021 were reported at 330,000 kg CO2e, while Scope 2 emissions were approximately 1,103,000 kg CO2e. Despite the increase in emissions, Maravai LifeSciences has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented reduction commitments suggests a need for further transparency regarding their climate strategies and long-term sustainability goals. Overall, Maravai LifeSciences is actively monitoring its emissions, but further commitments and reduction strategies would enhance its climate responsibility and align with industry standards for sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 330,000 | 000,000 | 0,000,000 |
| Scope 2 | 1,103,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Maravai LifeSciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
